ColoWrap Awarded Phase I SBIR Grant Award from National Science Foundation
Retrieved on:
Tuesday, September 14, 2021
Zero, Maimonides Medical Center, Bruise, Education, Science, Small Business Innovation Research, Splenic injury, NSF, Colonoscopy, Abdomen, Injury, R, Engineering, BMI, Technology, LLC, Patient, Colon, Company, Risk, SBIR, National Science Foundation, Physician, Endoscopy, Unitus Seed Fund, Torque, Colorectal cancer, Pain, Population, Nursing, Research, Johns Hopkins School of Medicine, Method, Pharmaceutical industry, Medical imaging
DURHAM, N.C., Sept. 14, 2021 /PRNewswire-PRWeb/ --ColoWrap, LLC., has been awarded a Phase I National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,000 to launch a new research and development (R&D) initiative aimed at adapting ColoWrap's existing anti-looping colonoscopy compression device to a new patient population.
Key Points:
- DURHAM, N.C., Sept. 14, 2021 /PRNewswire-PRWeb/ --ColoWrap, LLC., has been awarded a Phase I National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,000 to launch a new research and development (R&D) initiative aimed at adapting ColoWrap's existing anti-looping colonoscopy compression device to a new patient population.
- "We're thrilled to receive this SBIR award from the National Science Foundation," said James Hathorn, Chief Executive Officer of ColoWrap.
- "This grant validates the science behind ColoWrap and will serve to further secure its place as a vital tool in enhancing the practice of colonoscopy."
- In clinical trials, ColoWrap has been shown to shorten procedure time, improve patient comfort, and reduce staff-reported musculoskeletal pain by 85%.